Knowstox

Fundamentals snapshot

SkinHealth Systems Inc.

SKIN · NCM · Consumer Defensive · Household & Personal Products

Current price

$0.66

52-week range

$0.55 - $2.03

Market cap

$86.52M

One-glance verdict

Undervalued

$5.95 our estimate vs market $0.66

Wall Street consensus: $0.99 (-83.3% lower than our fair-value estimate)

Balance sheet

Distressed

-1.08x Concerning

Net debt $162.97M. Interest coverage shows how many times profit covers the interest bill.

What this company does

SkinHealth Systems Inc.

SkinHealth Systems sells professional skincare devices, like its popular HydraFacial machine, to spas and clinics. A large part of its business comes from selling the single-use tips and serums needed for every treatment, which creates recurring revenue (sales that are predictable because customers must keep buying these supplies). This is important because every new machine the company sells also creates a new, long-term customer for its disposable products.

Price history

How the share price has moved

—
Loading price history…

Earnings history

Last 8 quarters — what happened

Click any quarter to read the call summary and what the numbers say.

Free cash flow by quarter (oldest to newest)
FY2024 Q3 $10.31M FY2024 Q4 $16.40M FY2025 Q1 $2.95M FY2025 Q2 $9.55M FY2025 Q3 $9.62M FY2025 Q4 $15.06M FY2026 Q1 $-5.78M FY2026 Q2 $2.24M
Revenue $72.11M
Net income $-2.67M
Diluted EPS -0.02
Operating cash flow $2.67M
Free cash flow $2.24M
Revenue $64.91M
Net income $-6.63M
Diluted EPS -0.05
Operating cash flow $-5.55M
Free cash flow $-5.78M
Revenue $82.37M
Net income $-8.10M
Diluted EPS -0.02
Operating cash flow $15.20M
Free cash flow $15.06M
Revenue $70.66M
Net income $-11.03M
Diluted EPS -0.09
Operating cash flow $9.65M
Free cash flow $9.62M
Revenue $78.19M
Net income $19.71M
Diluted EPS 0.03
Operating cash flow $9.65M
Free cash flow $9.55M
Revenue $69.58M
Net income $-10.10M
Diluted EPS -0.08
Operating cash flow $3.00M
Free cash flow $2.95M
Revenue $83.50M
Net income $-10.33M
Diluted EPS -0.01
Operating cash flow $16.47M
Free cash flow $16.40M
Revenue $78.80M
Net income $-18.29M
Diluted EPS -0.15
Operating cash flow $10.31M
Free cash flow $10.31M

Is it cheap or expensive?

Fair value $5.95 vs current price $0.66

Wall Street consensus is the average analyst price target: $0.99 (-83.3% lower than our fair-value estimate).

Our most-likely fair value is $5.95 a share — about 795.3% above today's price of $0.66, so the stock currently looks cheap (undervalued).

undervalued

We estimate the cash this business should generate over the next 10 years and beyond, then convert it to today's money for a fair value per share, in its trading currency. Cautious, middle and optimistic growth cases give a range. Not for banks/insurers.

Base

Growth 8.0% · Discount 8.1% · Terminal 2.5%

$5.95

Bear

Growth 2.5% · Discount 8.1% · Terminal 2.5%

$3.99

Bull

Growth 15.0% · Discount 8.1% · Terminal 2.5%

$9.43

Is it drowning in debt?

Distressed

Net debt $163.0M. Interest coverage -1.1x.

Net debt $162.97M
Interest coverage -1.08x

SkinHealth Systems Inc.'s profit covers its interest bill about 0.0 times over. which is weaker than most peers shown here and 1 peers sit below 1x, which is the danger zone where profit does not fully cover the interest bill.

Distressed
Worse cushion Baseline Better cushion
SKIN BASELINE SkinHealth Systems Inc.

Total debt $367.04M Interest coverage -1.08x This is the baseline the peer rows are being compared against.

Total debt $4.45M Interest coverage 3.42x This peer still has a real interest-payment cushion, while SKIN does not.

Total debt $16.27M Interest coverage -2.98x Neither company has much profit cushion over interest right now.

What you should know

The case for and against SKIN

1 Reward 1 Risk

Rewards

  • Free cash flow was positive in 3/10 years.

Risks

  • Return on equity was -43.9% last year — the company lost money on shareholders' equity.

The numbers

All the key metrics, grouped by purpose

Tap any ? icon to learn what it means.

Valuation

How expensive the stock looks

P/E (TTM)
—
Forward P/E
3.50x
P/B
1.56x
P/S
0.30x
EV/EBITDA
12.42x
PEG ratio
0.93x

Profitability

How much profit each dollar creates

Gross margin
66.4%
Operating margin
5.0%
Net margin
-9.8%
ROE
-43.9%
ROA
-0.5%

Health

Liquidity and balance-sheet strength

Debt / equity
6.61x
Current ratio
1.75x
Quick ratio
1.33x
Total debt
$367.04M
Total cash
$204.07M

Growth

How the business has been compounding

Revenue TTM
$290.05M
Revenue 5Y CAGR
3.7%
EPS TTM
-0.23
EPS 5Y CAGR
—

Cash flow

How much cash the business throws off

Operating CF TTM
$21.96M
Free CF TTM
$37.18M
FCF margin
12.8%

Dividend

Shareholder payout

Yield
—
Payout ratio
0.0%
Last ex-div date
—